Astrana Health CFO surrenders 2,092 shares for taxes

The COO and CFO's reported position also includes unvested restricted stock and RSUs scheduled to vest in 2027, subject to continuous employment.

Rhea-AI Filing Summary

Astrana Health, Inc. COO and CFO Chandan Basho surrendered 2,092 common shares on October 2, 2026, to offset tax-withholding obligations associated with restricted stock units that vested that day. The reported price per share was $35.88. His resulting direct position was 155,728 shares, including unvested restricted stock and restricted stock units subject to continuous employment.

Insider Trade Summary

Tax Withholding: 2,092 shares

Tax Withholding 1 txn

Insider Basho Chandan

Role COO and CFO

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1, F2	2,092	$35.88	$75K

Holdings After Transaction: Common Stock — 155,728 shares (Direct)

Footnotes (2)

1. F1. Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on October 2, 2026.
2. F2. Includes 15,202 shares of unvested restricted stock which will vest on May 16, 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 11,703 restricted stock units, which will vest in three equal semi-annual installments beginning on April 2, 2027; and (ii) 16,690 restricted stock units, which will vest in five equal semi-annual installments beginning on March 5, 2027.

Key Figures

Common shares surrendered: 2,092 shares Reported price per share: $35.88 per share Direct position after transaction: 155,728 shares +3 more

6 metrics

Common shares surrendered 2,092 shares Surrendered to offset tax withholding obligations on October 2, 2026

Reported price per share $35.88 per share October 2, 2026 transaction

Direct position after transaction 155,728 shares Reported following the transaction

Unvested restricted stock 15,202 shares Vesting May 16, 2027, subject to continuous employment

Restricted stock units 11,703 units Three equal semi-annual installments beginning April 2, 2027, subject to continuous employment

Restricted stock units 16,690 units Five equal semi-annual installments beginning March 5, 2027, subject to continuous employment

Key Terms

tax withholding obligations, restricted stock units, unvested restricted stock, semi-annual installments, +1 more

5 terms

tax withholding obligations financial

"offset against tax withholding obligations"

restricted stock units financial

"certain restricted stock units that vested"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

unvested restricted stock financial

"15,202 shares of unvested restricted stock"

semi-annual installments financial

"vest in three equal semi-annual installments"

continuous employment financial

"subject to continuous employment with the Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did ASTH's COO and CFO report on October 2, 2026?

Chandan Basho, Astrana Health's COO and CFO, surrendered 2,092 common shares to offset tax-withholding obligations associated with restricted stock units that vested that day; the reported price per share was $35.88. His resulting direct position was 155,728 shares.

What restricted stock and RSUs are included in ASTH's reported holdings?

The 155,728-share reported position includes 15,202 shares of unvested restricted stock vesting May 16, 2027, plus 11,703 RSUs vesting in three equal semi-annual installments beginning April 2, 2027, and 16,690 RSUs vesting in five equal semi-annual installments beginning March 5, 2027. Each vesting is subject to continuous employment with the issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/06/2026 - 06:03 AM Accepted by SEC EDGAR 10/06/2026 - 06:01 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Basho Chandan

(Last) (First) (Middle)

C/O ASTRANA HEALTH, INC.

1668 S. GARFIELD AVENUE, 2ND FLOOR

(Street)

ALHAMBRA CALIFORNIA 91801

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Astrana Health, Inc. [ ASTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	COO and CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/02/2026		F		2,092(1)	D	$35.88	155,728(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on October 2, 2026.

2. Includes 15,202 shares of unvested restricted stock which will vest on May 16, 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 11,703 restricted stock units, which will vest in three equal semi-annual installments beginning on April 2, 2027; and (ii) 16,690 restricted stock units, which will vest in five equal semi-annual installments beginning on March 5, 2027.

	/s/ John Vong, as Attorney-in-Fact	10/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)